USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.97, $0.06 better than the analyst estimate of $0.91. Revenue for the quarter came in at $261.8 million versus the consensus estimate of $259.47 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.